Clinical Trial Update: Magnetic Resonance (MR) Imaging With Hyperpolarized Bicarbonate (13C) to Measure Tissue pH in Prostate Cancer [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 clinical trial is evaluating MR imaging with hyperpolarized bicarbonate (13C) to measure tissue pH in localized prostate cancer; the study is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Localized Prostate Carcinoma
• Prostate Cancer

Drugs mentioned

• Hyperpolarized Bicarbonate (13C) (13C-labeled bicarbonate)

Snippet

Sponsor: Robert Flavell, MD, PhD | Conditions: Prostate Cancer, Localized Prostate Carcinoma | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING